bioAffinity Technologies Inc BIAF:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
1.88quote price arrow up+0.01 (+0.53%)
Volume
70,476
52 week range
0.95 - 3.62
Loading...
  • Open1.86
  • Day High1.94
  • Day Low1.80
  • Prev Close1.87
  • 52 Week High3.62
  • 52 Week High Date03/05/24
  • 52 Week Low0.95
  • 52 Week Low Date09/26/23

Key Stats

  • Market Cap21.647M
  • Shares Out11.51M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change27.85

KEY STATS

  • Open1.86
  • Day High1.94
  • Day Low1.80
  • Prev Close1.87
  • 52 Week High3.62
  • 52 Week High Date03/05/24
  • 52 Week Low0.95
  • 52 Week Low Date09/26/23
  • Market Cap21.647M
  • Shares Out11.51M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change27.85

RATIOS/PROFITABILITY

  • EPS (TTM)-0.90
  • P/E (TTM)-2.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-7.578M
  • ROE (TTM)-99.84%
  • Revenue (TTM)2.533M
  • Gross Margin (TTM)31.26%
  • Net Margin (TTM)-313.41%
  • Debt To Equity (MRQ)24.73%

EVENTS

  • Earnings Date08/14/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On bioAffinity Technologies Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
bioAffinity Technologies, Inc. is a biotechnology company focused on commercializing noninvasive tests for the detection of early-stage cancer and lung disease. The Company addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. It develops noninvasive diagnostic tests using flow cytometry and automated analysis developed by artificial intelligence (AI). Its diagnostic tests analyze cell populations...
Steven Girgenti
Executive Chairman of the Board
Maria Zannes J.D.
President, Chief Executive Officer, Founder, Director
Michael Dougherty
Chief Financial Officer, Principal Accounting Officer, Vice President
Timothy Zannes J.D.
Executive Vice President, General Counsel, Secretary
Vivienne Rebel M.D., Ph.D.
Executive Vice President, Chief Science and Medical Officer
Address
22211 West Interstate-10, Suite 1206
San Antonio, TX
78257
United States